JNJ.DE · JOHNSON + JOHNSON DL 1
Germany · RS rating 72 · As of 2026-10-14
| Price | 227.00 EUR |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 47 / 61 / 81 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 45 / 39 |
| Industry group (rank) | Medical-Ethical Drugs (–) |
| EPS growth Q/Q | +6.1% |
| Sales growth Q/Q | +5.2% |
| Distance from 52-week high | +5.2% |
| Market cap (USD) | $623.6B |